UB Paderborn / Katalog / Suche / in CDI

Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure

Proceedings of the National Academy of Sciences - PNAS, 2018-11, Vol.115 (48), p.E11369-E11378

2018

Volltextzugriff (PDF)

Monoclonal antibody therapies against anthrax

Toxins, 2011-08, Vol.3 (8), p.1004-1019

2011

Volltextzugriff (PDF)

B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure

Proceedings of the National Academy of Sciences - PNAS, 2010-05, Vol.107 (19), p.8766-8771

2010

Volltextzugriff (PDF)

Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans

PLoS pathogens, 2020-08, Vol.16 (8), p.e1008793-e1008793

2020

Volltextzugriff (PDF)

Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees

mBio, 2020-11, Vol.11 (6)

2020

Volltextzugriff (PDF)

Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis

Journal of Virology, 2013-09, Vol.87 (17), p.9547-9557

2013

Volltextzugriff (PDF)

Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor

Proceedings of the National Academy of Sciences - PNAS, 2013-12, Vol.110 (50), p.20242-20247

2013

Volltextzugriff (PDF)

Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis

Journal of Virology, 2011-05, Vol.85 (9), p.4354-4362

2011

Volltextzugriff (PDF)

Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (32), p.13487-13492

2009

Volltextzugriff (PDF)

Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles

Clinical and Vaccine Immunology, 2009-03, Vol.16 (3), p.408-413

2009

Volltextzugriff (PDF)

Mouse Monoclonal Antibodies to Anthrax Edema Factor Protect against Infection

Infection and Immunity, 2011-11, Vol.79 (11), p.4609-4616

2011

Volltextzugriff (PDF)

Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody

Infection and Immunity, 2009-09, Vol.77 (9), p.3902-3908

2009

Volltextzugriff (PDF)

Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule

Proceedings of the National Academy of Sciences - PNAS, 2011-01, Vol.108 (2), p.739-744

2011

Volltextzugriff (PDF)

Characterization of Chimpanzee/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein and Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse Protection Model

Journal of Virology, 2007-09, Vol.81 (17), p.8989-8995

2007

Volltextzugriff (PDF)

Chimpanzee/Human mAbs to Vaccinia Virus B5 Protein Neutralize Vaccinia and Smallpox Viruses and Protect Mice against Vaccinia Virus

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (6), p.1882-1887

2006

Volltextzugriff (PDF)

Progress Planning Method of Strength Quality Training of Volleyball Players Based on Data Mining

Mathematical problems in engineering, 2022-05, Vol.2022, p.1-11

2022

Volltextzugriff (PDF)

Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice

Critical care medicine, 2011-06, Vol.39 (6), p.1439-1447

2011

Volltextzugriff (PDF)

Efficient Neutralization of Anthrax Toxin by Chimpanzee Monoclonal Antibodies against Protective Antigen

The Journal of infectious diseases, 2006-03, Vol.193 (5), p.625-633

2006

Volltextzugriff (PDF)

Next‐generation sequencing of the intrahepatic antibody repertoire delineates a unique B‐cell response in HBV‐associated acute liver failure

Journal of viral hepatitis, 2020-08, Vol.27 (8), p.847-851

2020

Volltextzugriff (PDF)

Rapid Discovery and Characterization of Synthetic Neutralizing Antibodies against Anthrax Edema Toxin

Biochemistry (Easton), 2019-07, Vol.58 (27), p.2996-3004

2019

Volltextzugriff (PDF)

Structural basis of anthrax edema factor neutralization by a neutralizing antibody

Biochemical and biophysical research communications, 2012-01, Vol.417 (1), p.324-329

2012

Volltextzugriff (PDF)

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

Cell reports (Cambridge), 2022-11, Vol.41 (5), p.111528, Article 111528

2022

Volltextzugriff (PDF)

A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses

Journal of clinical virology, 2015-04, Vol.65, p.32-37

2015

Volltextzugriff (PDF)

Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax

Analytical and bioanalytical chemistry, 2019-05, Vol.411 (12), p.2493-2509

2019

Volltextzugriff (PDF)

Is the Immune System Impaired in Patients with Severe Acute Respiratory Syndrome?

Clinical infectious diseases, 2004-03, Vol.38 (6), p.921-922

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Role of humoral immunity against hepatitis B virus core antigen in the pathogenesis of acute liver failure

Monoclonal antibody therapies against anthrax

B cell gene signature with massive intrahepatic production of antibodies to hepatitis B core antigen in hepatitis B virus-associated acute liver failure

Distinct disease features in chimpanzees infected with a precore HBV mutant associated with acute liver failure in humans

Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees

Development of Norwalk Virus-Specific Monoclonal Antibodies with Therapeutic Potential for the Treatment of Norwalk Virus Gastroenteritis

Cross-neutralizing human anti-poliovirus antibodies bind the recognition site for cellular receptor

Chimpanzee-Human Monoclonal Antibodies for Treatment of Chronic Poliovirus Excretors and Emergency Postexposure Prophylaxis

Potent neutralization of anthrax edema toxin by a humanized monoclonal antibody that competes with calmodulin for edema factor binding

Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles

Mouse Monoclonal Antibodies to Anthrax Edema Factor Protect against Infection

Novel Chimpanzee/Human Monoclonal Antibodies That Neutralize Anthrax Lethal Factor, and Evidence for Possible Synergy with Anti-Protective Antigen Antibody

Pre- and postexposure protection against virulent anthrax infection in mice by humanized monoclonal antibodies to Bacillus anthracis capsule

Characterization of Chimpanzee/Human Monoclonal Antibodies to Vaccinia Virus A33 Glycoprotein and Its Variola Virus Homolog In Vitro and in a Vaccinia Virus Mouse Protection Model

Chimpanzee/Human mAbs to Vaccinia Virus B5 Protein Neutralize Vaccinia and Smallpox Viruses and Protect Mice against Vaccinia Virus

Progress Planning Method of Strength Quality Training of Volleyball Players Based on Data Mining

Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice

Efficient Neutralization of Anthrax Toxin by Chimpanzee Monoclonal Antibodies against Protective Antigen

Next‐generation sequencing of the intrahepatic antibody repertoire delineates a unique B‐cell response in HBV‐associated acute liver failure

Rapid Discovery and Characterization of Synthetic Neutralizing Antibodies against Anthrax Edema Toxin

Structural basis of anthrax edema factor neutralization by a neutralizing antibody

Potent monoclonal antibodies neutralize Omicron sublineages and other SARS-CoV-2 variants

A single chimpanzee-human neutralizing monoclonal antibody provides post-exposure protection against type 1 and type 2 polioviruses

Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax

Is the Immune System Impaired in Patients with Severe Acute Respiratory Syndrome?

Suchergebnisse filtern